English translation for this page is not available

Vorige

J.J.C. (Joost) Verhoeff

Radiotherapeut-oncoloog

Publicaties

Key publications

  • Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme. Verhoeff JJ, van Tellingen O, Claes A, Stalpers LJ, van Linde ME, Richel DJ, Leenders WP, van Furth WR. BMC Cancer. 2009 Dec 16;9:444. Review. PMID: 20015387
  • Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma. Verhoeff JJ, Lavini C, van Linde ME, Stalpers LJ, Majoie CB, Reijneveld JC, van Furth WR, Richel DJ. Ann Oncol. 2010 Aug;21(8):1723-7. PMID:20064829
  • Bowel perforation after radiotherapy in a patient receiving sorafenib. Peters NA, Richel DJ, Verhoeff JJ, Stalpers LJ. J Clin Oncol. 2008 May 10;26(14):2405-6. PMID:18467733
  • Cancer stem cell tumor model reveals invasive morphology and increased phenotypical heterogeneity. Sottoriva A, Verhoeff JJ, Borovski T, McWeeney SK, Naumov L, Medema JP, Sloot PM, Vermeulen L. Cancer Res. 2010 Jan 1;70(1):46-56. PMID:20048071
  • Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma. Svendsen A, Verhoeff JJ, Immervoll H, Brøgger JC, Kmiecik J, Poli A, Netland IA, Prestegarden L, Planagumà J, Torsvik A, Kjersem AB, Sakariassen PØ, Heggdal JI, Van Furth WR, Bjerkvig R, Lund-Johansen M, Enger PØ, Felsberg J, Brons NH, Tronstad KJ, Waha A, Chekenya M. Acta Neuropathol. 2011 Oct;122(4):495-510. PMID:21863242

 

Persoonlijke prijzen, subsidies en onderscheidingen